PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
AMPH vs. AVGO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


AMPHAVGO
YTD Return-34.60%49.22%
1Y Return-30.71%99.72%
3Y Return (Ann)26.12%56.75%
5Y Return (Ann)14.43%47.85%
Sharpe Ratio-0.662.64
Daily Std Dev42.84%37.35%
Max Drawdown-49.92%-48.30%
Current Drawdown-37.77%-9.31%

Fundamentals


AMPHAVGO
Market Cap$1.99B$778.08B
EPS$2.91$23.18
PE Ratio13.9672.43
PEG Ratio2.771.56
Total Revenue (TTM)$676.21M$30.13B
Gross Profit (TTM)$362.00M$19.25B
EBITDA (TTM)$239.32M$15.58B

Correlation

-0.50.00.51.00.2

The correlation between AMPH and AVGO is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

AMPH vs. AVGO - Performance Comparison

In the year-to-date period, AMPH achieves a -34.60% return, which is significantly lower than AVGO's 49.22% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%500.00%1,000.00%1,500.00%2,000.00%2,500.00%3,000.00%3,500.00%2024FebruaryMarchAprilMayJune
362.29%
2,942.81%
AMPH
AVGO

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Amphastar Pharmaceuticals, Inc.

Broadcom Inc.

Risk-Adjusted Performance

AMPH vs. AVGO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Amphastar Pharmaceuticals, Inc. (AMPH) and Broadcom Inc. (AVGO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


AMPH
Sharpe ratio
The chart of Sharpe ratio for AMPH, currently valued at -0.66, compared to the broader market-2.00-1.000.001.002.003.00-0.66
Sortino ratio
The chart of Sortino ratio for AMPH, currently valued at -0.73, compared to the broader market-4.00-2.000.002.004.006.00-0.73
Omega ratio
The chart of Omega ratio for AMPH, currently valued at 0.90, compared to the broader market0.501.001.502.000.90
Calmar ratio
The chart of Calmar ratio for AMPH, currently valued at -0.70, compared to the broader market0.002.004.006.00-0.70
Martin ratio
The chart of Martin ratio for AMPH, currently valued at -1.14, compared to the broader market-5.000.005.0010.0015.0020.0025.00-1.14
AVGO
Sharpe ratio
The chart of Sharpe ratio for AVGO, currently valued at 2.64, compared to the broader market-2.00-1.000.001.002.003.002.64
Sortino ratio
The chart of Sortino ratio for AVGO, currently valued at 3.52, compared to the broader market-4.00-2.000.002.004.006.003.52
Omega ratio
The chart of Omega ratio for AVGO, currently valued at 1.42, compared to the broader market0.501.001.502.001.42
Calmar ratio
The chart of Calmar ratio for AVGO, currently valued at 7.03, compared to the broader market0.002.004.006.007.03
Martin ratio
The chart of Martin ratio for AVGO, currently valued at 17.61, compared to the broader market-5.000.005.0010.0015.0020.0025.0017.61

AMPH vs. AVGO - Sharpe Ratio Comparison

The current AMPH Sharpe Ratio is -0.66, which is lower than the AVGO Sharpe Ratio of 2.64. The chart below compares the 12-month rolling Sharpe Ratio of AMPH and AVGO.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.002024FebruaryMarchAprilMayJune
-0.66
2.64
AMPH
AVGO

Dividends

AMPH vs. AVGO - Dividend Comparison

AMPH has not paid dividends to shareholders, while AVGO's dividend yield for the trailing twelve months is around 0.91%.


TTM20232022202120202019201820172016201520142013
AMPH
Amphastar Pharmaceuticals, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
AVGO
Broadcom Inc.
0.91%1.71%3.02%2.24%3.05%3.54%4.48%1.94%1.52%1.23%1.34%1.87%

Drawdowns

AMPH vs. AVGO - Drawdown Comparison

The maximum AMPH drawdown since its inception was -49.92%, roughly equal to the maximum AVGO drawdown of -48.30%. Use the drawdown chart below to compare losses from any high point for AMPH and AVGO. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%2024FebruaryMarchAprilMayJune
-37.77%
-9.31%
AMPH
AVGO

Volatility

AMPH vs. AVGO - Volatility Comparison

The current volatility for Amphastar Pharmaceuticals, Inc. (AMPH) is 6.95%, while Broadcom Inc. (AVGO) has a volatility of 16.55%. This indicates that AMPH experiences smaller price fluctuations and is considered to be less risky than AVGO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


6.00%8.00%10.00%12.00%14.00%16.00%18.00%2024FebruaryMarchAprilMayJune
6.95%
16.55%
AMPH
AVGO

Financials

AMPH vs. AVGO - Financials Comparison

This section allows you to compare key financial metrics between Amphastar Pharmaceuticals, Inc. and Broadcom Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items